Abstracts 2022 - CCORC

Efficacy and Safety of Older Adults with Chronic Pain using Medical Marijuana

jhouder May 17, 2022 Abstracts 2022 0 Comments

Lenny Chiang-Hanisko Florida Atlantic University

Read more →

Medical Marijuana & Me (M3): A New Combined Cohort/Cross-sectional Study of Medical Marijuana Users in Florida

jhouder May 17, 2022 Abstracts 2022 0 Comments

Ruba Sajdeya University of Florid

Read more →

Tracking real-time changes in anxiety/ depression among Florida cannabis consumers using Releaf App and exploring user demographics connected to relief outcome.

jhouder May 17, 2022 Abstracts 2022 0 Comments

Tyler Dautrich Releaf App

Read more →

The co-presence of opioids in Cannabinoidrelated mortality during the COVID-19 pandemic in Florida

jhouder May 17, 2022 Abstracts 2022 0 Comments

Armiel Suriaga Florida Atlantic University

Read more →

R/THCO: A Rapid Netnographic Examination of THC-OAcetate

jhouder May 17, 2022 Abstracts 2022 0 Comments

Carlton Bone Portland State University

Read more →

2022: Synthetic cannabinoids as a host-targeting approach to reduce inflammation and clear intracellular infection

jhouder May 17, 2022 Abstracts 2022 0 Comments

Hailey Barker University of Florida

Read more →

2022: Extracellular Vesicles from Human Umbilical Cord Mesenchymal Stem Cells Loaded with Cannabidiol Alleviate Paclitaxel Induced Peripheral Neuropathy

jhouder May 17, 2022 Abstracts 2022 0 Comments

Mandip Singh Sachdeva Florida A&M University

Read more →

2022: Evaluation of Cannabis constituents in a model of phantom limb pain in rats

jhouder May 17, 2022 Abstracts 2022 0 Comments

Anjalika Eeswara University of Miami

Read more →

2022: Proteomics and Transcriptomics Uncover the Molecular Targets of CBD and THCV in the Sensitization of Doxorubicin against DOX-resistant MDAMB 231 Xenografts

jhouder May 17, 2022 Abstracts 2022 0 Comments

Mandip Singh Sachdeva Florida A&M University

Read more →

2022: Transcriptomic Analysis of Cannabidiol and Tetrahydrocannabivarin Revealed New Molecular Targets for Treatment of Experimental Diabetic Neuropathy

jhouder May 17, 2022 Abstracts 2022 0 Comments

Anil Kumar Kalvala Florida A&M University

Read more →

Category: Abstracts 2022

Efficacy and Safety of Older Adults with Chronic Pain using Medical Marijuana

Medical Marijuana & Me (M3): A New Combined Cohort/Cross-sectional Study of Medical Marijuana Users in Florida

Tracking real-time changes in anxiety/ depression among Florida cannabis consumers using Releaf App and exploring user demographics connected to relief outcome.

The co-presence of opioids in Cannabinoidrelated mortality during the COVID-19 pandemic in Florida

R/THCO: A Rapid Netnographic Examination of THC-OAcetate

2022: Synthetic cannabinoids as a host-targeting approach to reduce inflammation and clear intracellular infection

2022: Extracellular Vesicles from Human Umbilical Cord Mesenchymal Stem Cells Loaded with Cannabidiol Alleviate Paclitaxel Induced Peripheral Neuropathy

2022: Evaluation of Cannabis constituents in a model of phantom limb pain in rats

2022: Proteomics and Transcriptomics Uncover the Molecular Targets of CBD and THCV in the Sensitization of Doxorubicin against DOX-resistant MDAMB 231 Xenografts

2022: Transcriptomic Analysis of Cannabidiol and Tetrahydrocannabivarin Revealed New Molecular Targets for Treatment of Experimental Diabetic Neuropathy

Contact

CONSORTIUM FOR MEDICAL MARIJUANA CLINICAL OUTCOMES RESEARCH